Navigation Links
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes
Date:8/6/2014

icant risks and uncertainties.  Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with market conditions, whether the Issuer will offer the notes or whether Jazz Pharmaceuticals plc and the Issuer will be able to consummate the proposed offering at the anticipated size and on the anticipated terms, or at all, and the satisfaction of closing conditions related to the proposed offering; Jazz Pharmaceuticals' ability to identify and acquire, in-license or develop additional products or product candidates to grow its business; and possible restrictions on Jazz Pharmaceuticals' ability and flexibility to pursue certain future opportunities as a result of its substantial outstanding debt obligations.  These and other risks and uncertainties relating to Jazz Pharmaceuticals and its business can be found under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals plc's Securities and Exchange Commission filings and reports (Commission File No. 001-33500), including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 and future filings and reports by Jazz Pharmaceuticals plc.  Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events or changes in its expectations. 


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rock Creek Pharmaceuticals Expands The Board with the Appointment of Two Independent Directors
2. Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update
3. Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.
4. Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance
5. Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results
6. Avanir Pharmaceuticals to Participate in Two Conferences in August
7. Heritage Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd.
8. Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)
9. Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13
10. Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information
11. Rock Creek Pharmaceuticals to Present at the Annual BioPharm America International Partnering Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced completion of enrollment in its first ... the 3-month observations confirmed the 1-month findings that ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/17/2014)... PCCA received the Autism Hope Alliance,s ... program seal for best practices in meeting needs ... practices, materials and goods that meet strict criteria ... affected by autism often have unique physical or ... found in food and medicine – for instance ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 30, 2011 Unilife Corporation ("Unilife" or the "Company") ... its preliminary financial results for the fourth quarter and ... Corporate Highlights: Completed construction of new ... and successfully relocated entire staff (December 2010) Appointed ...
... Aug. 30, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Paul Bisaro, Watson,s President and Chief Executive Officer, will provide ... 2011 Morgan Stanley Global Healthcare Conference on Tuesday, September 13, ... New York in New York City. The presentation will be ...
Cached Medicine Technology:Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 2Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 3Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 4Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 5Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 6Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 7Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 8Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 9Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 10
(Date:12/21/2014)... When families in Coral Gables get hit ... The new answer is Lice Troopers . Located at ... newest treatment center will be the new go-to resource for ... the use of harmful chemicals or pesticides. , ... 2015. Like the company’s first clinic (located at 1005 Kane ...
(Date:12/21/2014)... New York, New York (PRWEB) December 21, 2014 ... http://www.byettalawsuit2013.com/ ) and other product liability claims involving ... as incretin mimetics continue to move forward in ... District Court, Southern District of California, Bernstein Liebhard ... 17th, the Court has established a data cut-off ...
(Date:12/21/2014)... Recently, one of the best prom dresses ... has introduced its new collection of 2015 prom ... on all its prom dresses & other fashionable designs, ... providing top quality dress products and great customer services ... one of the best prom dresses online shops around ...
(Date:12/21/2014)... AlignLife of Norton Shores is ... the same time helping people get their health back. ... committed to serving those persons in Muskegon County who are ... the quality of life. Dr. Michael Rykse wanted to do ... local community and he knew he found that when he ...
(Date:12/21/2014)... AZ (PRWEB) December 21, 2014 Parker ... range of heating, cooling, plumbing and other similar home ... in 2014 with regard to its expert contracting services. ... industry leader that has been serving Arizona for well ... in providing the absolute best in quality customer service ...
Breaking Medicine News(10 mins):Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3
... April 23 President,George W. Bush personally recognized ... Quality Award at a private event at the ... organizations in the country,and the only one in ... highest Presidential honor for quality and organizational,performance excellence., ...
... for future research , , WEDNESDAY, April 23 (HealthDay News) ... Alzheimer,s disease appears to hasten progress of a related ... a new study. , The surprising findings, published in ... of Clinical Investigation , are significant, because individuals with ...
... April 23 NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ... and hospitals throughout the United States,today announced that it ... at 4:30 p.m. (EDT) with management to review the ... Web Cast, A live and archived webcast will ...
... and Mikulski to quickly pass,companion bill and send measure ... the,supporters and cosponsors of the Protecting the Medicaid Safety ... House of Representatives. The bill,prevents massive increases in costs ... the administration., "Today,s vote is a victory for ...
... oversulfated chondroitin sulphate caused deaths, reactions , , WEDNESDAY, April ... that lots of the blood thinner heparin pulled from ... oversulfated chondroitin sulfate. , The findings were published ... according to a paper published online simultaneously in the ...
... leaders are,rediscovering the importance of strong competitive intelligence ... today,s economic,environment, according to a new study by ... -- Competitive Intelligence adds value and gains,buy-in through ... actionable insights that have a financial impact for ...
Cached Medicine News:Health News:President Recognizes Sharp HealthCare With 2007 Malcolm Baldrige National Quality Award at White House 2Health News:Enzyme Beneficial to Alzheimer's Plays Darker Role in Other Dementia 2Health News:NightHawk Radiology Holdings, Inc. to Host Conference Call to Discuss First Quarter 2008 Earnings Results 2Health News:AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid 2Health News:Researchers Identify Contaminant in Tainted Heparin 2Health News:Researchers Identify Contaminant in Tainted Heparin 3Health News:Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: